VANCOUVER, British Columbia, October 24, 2017 – Reliq Health Technologies Inc. (TSXV:RHT) (OTCQB:RQHTF) (“Reliq” or the “Company”), a technology company focused on developing innovative mobile health (mHealth) and telemedicine solutions for Community-Based Healthcare, is pleased to announce that the Company’s CEO Dr. Lisa Crossley will be presenting at the StableView Asset Management TECH17 Conference in Toronto, ON on Thursday, October 26, 2017 at 10:45am.
“We are excited to be a part of StableView’s annual conference and look forward to sharing our progress and business plan for growth with attendees,” said Reliq Health CEO, Dr. Lisa Crossley.
About StableView TECH17
StableView Asset Management hosts StableView Tech17. The 4th annual StableView TECH17 showcases the most innovative ideas, themes and challenges in Technology today. As the only buy-side curated tech conference in Canada, StableView TECH17 sits at the junction of the public and private investing tech ecosystem in Canada and brings together participants that typically stay in their individual silos: institutional investors, pensions, VCs, broker-dealers, advisors, HNW investors and family offices with private and public tech companies in Canada.
On October 26th, 2017, approximately 25 of Canada’s leading technology companies will be presenting to an expected audience of over 450+ professionals representing approximately $350B in AUM.
About Reliq Health Technologies
Reliq Health Technologies is a healthcare technology company that specializes in developing innovative software solutions for the Community Care market. Reliq’s powerful iUGO Care platform supports care coordination and community-based healthcare. The iUGO Care platform integrates wearables, sensors, voice technology and intuitive mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. iUGO Care allows complex patients to receive high quality care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. Our platform provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent costly hospital readmissions and ER visits. Reliq Health Technologies trades on the TSX Venture under the symbol RHT and on the OTCQB as RQHTF.
ON BEHALF OF THE BOARD
“Dr. Lisa Crossley”
CEO and Director
For further information contact:
Renmark Financial Communications Inc.
Laura Welsh: firstname.lastname@example.org
Tel: (416) 644-2020 or (514) 939-3989
or CORE Capital Partners at 604-566-9233 or email@example.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Cautionary Statements Regarding Forward Looking Information
Certain statements in this press release constitute forward-looking statements, within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements”.
We caution you that such “forward-looking statements” involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements.
Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including technology development, anticipated revenues, projected size of market, and other information that is based on forecasts of future results, estimates of amounts not yet determinable and assumptions of management.
Reliq Health Technologies Inc. (the “Company“) does not intend, and does not assume any obligation, to update these forward-looking statements except as required by law. These forward-looking statements involve risks and uncertainties relating to, among other things, technology development and marketing activities, the Company’s historical experience with technology development, uninsured risks. Actual results may differ materially from those expressed or implied by such forward-looking statements.
SOURCE: Reliq Health Technologies Inc.